Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Triveni Bio

News headline image
Triveni Bio Doses First Patient in Global Phase 2 Proof-of-Concept Study of TRIV-573 in Atopic Dermatitis and Provides I&I Pipeline Update
From Triveni Bio
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.